Still calculating financial ratios manually?
Stop wasting time — let the computer do it!
Chemomab Therapeutics Ltd. (CMMB) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
KIRYAT ATIDIM, BUILDING 7 TEL AVIV, 6158002 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 13,519,000 | 10,741,000 | 9,883,000 | 13,827,000 | 15,186,000 | 37,744,000 | |||
| Cash and cash equivalent | 13,519,000 | 10,741,000 | 9,883,000 | 13,827,000 | 15,186,000 | 37,744,000 | |||
| Restricted cash and investments | 77,000 | ||||||||
| Prepaid expense | 1,307,000 | 1,348,000 | |||||||
| Deposits current assets | 26,374,000 | 35,725,000 | 41,841,000 | 43,579,000 | 45,975,000 | 26,524,000 | |||
| Other undisclosed current assets | 459,000 | 2,259,000 | 3,106,000 | 1,934,000 | 179,000 | 1,574,000 | |||
| Total current assets: | 41,736,000 | 48,725,000 | 54,830,000 | 59,340,000 | 62,688,000 | 65,842,000 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 227,000 | 261,000 | 295,000 | 309,000 | 345,000 | 359,000 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 367,000 | 380,000 | 355,000 | 358,000 | 357,000 | 234,000 | |||
| Prepaid expense | 733,000 | 776,000 | 821,000 | 864,000 | 908,000 | 952,000 | |||
| Restricted cash and investments | 77,000 | 77,000 | 85,000 | 55,000 | 53,000 | ||||
| Total noncurrent assets: | 1,327,000 | 1,494,000 | 1,548,000 | 1,616,000 | 1,665,000 | 1,598,000 | |||
| TOTAL ASSETS: | 43,063,000 | 50,219,000 | 56,378,000 | 60,956,000 | 64,353,000 | 67,440,000 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 5,066,000 | 5,351,000 | 4,262,000 | 3,401,000 | 2,544,000 | 1,569,000 | |||
| Employee-related liabilities | ✕ | ✕ | 1,527,000 | 1,117,000 | 666,000 | 653,000 | 451,000 | ||
| Accounts payable | 1,688,000 | 1,247,000 | 1,433,000 | 1,487,000 | 1,336,000 | 481,000 | |||
| Accrued liabilities | 3,378,000 | 2,577,000 | 1,712,000 | 1,248,000 | 555,000 | 637,000 | |||
| Other undisclosed current liabilities | 1,683,000 | 126,000 | 132,000 | 116,000 | 106,000 | 61,000 | |||
| Total current liabilities: | 6,749,000 | 5,477,000 | 4,394,000 | 3,517,000 | 2,650,000 | 1,630,000 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 118,000 | 148,000 | 203,000 | 237,000 | 298,000 | ||||
| Liabilities, other than long-term debt | 91,000 | ||||||||
| Operating lease, liability | 91,000 | 118,000 | 148,000 | 203,000 | 237,000 | 298,000 | |||
| Other undisclosed noncurrent liabilities | (118,000) | (148,000) | (203,000) | (298,000) | |||||
| Total noncurrent liabilities: | 91,000 | 118,000 | 148,000 | 203,000 | 237,000 | 298,000 | |||
| Total liabilities: | 6,840,000 | 5,595,000 | 4,542,000 | 3,720,000 | 2,887,000 | 1,928,000 | |||
| Equity | |||||||||
| Equity, attributable to parent | 36,223,000 | 44,624,000 | 51,836,000 | 57,236,000 | 61,466,000 | 65,512,000 | |||
| Treasury stock, value | (1,218,000) | ||||||||
| Additional paid in capital | 101,260,000 | 100,171,000 | 99,303,000 | 98,513,000 | 97,639,000 | 96,649,000 | |||
| Accumulated deficit | (63,819,000) | (55,547,000) | (47,467,000) | (41,277,000) | (36,173,000) | (31,137,000) | |||
| Total equity: | 36,223,000 | 44,624,000 | 51,836,000 | 57,236,000 | 61,466,000 | 65,512,000 | |||
| TOTAL LIABILITIES AND EQUITY: | 43,063,000 | 50,219,000 | 56,378,000 | 60,956,000 | 64,353,000 | 67,440,000 | |||
Income Statement (P&L) (USD)Annual | Quarterly
| 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (8,642,000) | (8,317,000) | (6,254,000) | (5,320,000) | (5,024,000) | (2,891,000) | ||
| Other undisclosed operating loss | (5,142,000) | (3,310,000) | ||||||
| Operating loss: | (13,784,000) | (8,317,000) | (6,254,000) | (5,320,000) | (8,334,000) | (2,891,000) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 353,000 | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (13,431,000) | (8,317,000) | (6,254,000) | (5,320,000) | (8,334,000) | (2,891,000) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 5,169,000 | 237,000 | (480,000) | 28,155,000 | ||||
| Income (loss) from continuing operations before income taxes: | (8,262,000) | (8,080,000) | (6,734,000) | (5,320,000) | 19,821,000 | (2,891,000) | ||
| Income tax expense (benefit) | (10,000) | 544,000 | ||||||
| Income (loss) from continuing operations: | (8,272,000) | (8,080,000) | (6,190,000) | (5,320,000) | 19,821,000 | (2,891,000) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | (8,080,000) | (6,190,000) | (5,320,000) | 19,821,000 | (2,891,000) | |
| Other undisclosed net income (loss) | 216,000 | (24,857,000) | ||||||
| Net loss: | (8,272,000) | (8,080,000) | (6,190,000) | (5,104,000) | (5,036,000) | (2,891,000) | ||
| Other undisclosed net loss attributable to parent | (77,000) | |||||||
| Net loss available to common stockholders, diluted: | (8,272,000) | (8,080,000) | (6,190,000) | (5,104,000) | (5,036,000) | (2,968,000) | ||
Comprehensive Income (USD)Annual | Quarterly
| 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (8,272,000) | (8,080,000) | (6,190,000) | (5,104,000) | (5,036,000) | (2,891,000) | ||
| Comprehensive loss, net of tax, attributable to parent: | (8,272,000) | (8,080,000) | (6,190,000) | (5,104,000) | (5,036,000) | (2,891,000) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.
An easy way to get professional financial analysis in one click
Load financial statements → click "Get report" → Your report is ready.
No financial analysis knowledge required!